Whitehawk Therapeutics, Inc. Common Stock WHWK Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 89.4%+1.0pp | 88.4%-0.1pp | 88.5%— | —— | |
| Operating margin | -1,601.1%-1,341pp | -259.6%+35.7pp | -295.4%— | —— | |
| Net margin | -288.3%-43.1pp | -245.1%+24.9pp | -270%— | —— | |
| Returns | |||||
| Return on equity | -21.8%+59.0pp | -80.8%-30.9pp | -49.9%— | —— | |
| Efficiency | |||||
| Asset turnover | 0.1×-0.2× | 0.3×+0.1× | 0.2×— | —— | |
| Liquidity | |||||
| Current ratio | 10.3×+6.7× | 3.6×-1.1× | 4.7×-4.8× | 9.6×-0.3× | |
| Per Share | |||||
| Book value per share | $2.20+13.4% | $1.94-50.3% | $3.91-44.5% | $7.04-54.0% | |
| Valuation | |||||
| Market capitalization | $226.49M+131% | —— | —— | —— | |
| Price / sales | 16×— | —— | —— | —— | |
| Price / book | 1.8×+1.3× | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Whitehawk Therapeutics, Inc. Common Stock's profit margins?
- Whitehawk Therapeutics, Inc. Common Stock (WHWK) runs a 89.4% gross margin and a -1601.1% operating margin, with a -288.3% net margin.
- Where do Whitehawk Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Whitehawk Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.